Arnica montana has been widely used as a homeopathic remedy for the treatment of several inflammatory conditions in pain management and postoperative settings. This review gives an overview of the therapeutic use of Arnica montana in the above-mentioned fields also focusing on its mechanisms of action learned from animal models and in vitro studies. Arnica montana is more effective than placebo when used for the treatment of several conditions including post-traumatic and postoperative pain, edema, and ecchymosis. However, its dosages and preparations used have produced substantial differences in the clinical outcome. Cumulative evidence suggests that Arnica montana may represent a valid alternative to non-steroidal anti-inflammatory drugs, at least when treating some specific conditions.
INTRODUCTION
The use of complementary therapies, including plant remedies, is widespread and rapidly expanding on a worldwide scale. Plant remedies are traditionally used in a variety of pharmacopoeias and on a large scale of doses, including extremely low-dose homeopathic formulations. Herbal medicine or botanical medicine or phytomedicine refers to the therapeutic use of herbs, herbal materials, herbal preparations, and finished herbal products containing plant materials (seeds, berries, roots, leaves, bark, or flowers) or parts as active ingredients. Homeopathy is based on the concept "similia similibus curentur" 1 according to which symptoms, caused by the original substance in healthy subjects, can be reversed by the homeopathic remedy in patients having similar symptoms. Therefore, homeopathic drug administration is based on 3 principles: (1) the administration of an active element to healthy volunteers brings manifestation of a series of clinical symptoms at physical and psychological levels; (2) low doses of the same element(s) reverse pathological states in ill organisms presenting a similar symptomatologic pattern; (3) the homeopathic treatment retains its biological activity because of a peculiar method of dilution followed by vigorous shaking, that is, "succussion", even if, after several successive serial dilutions, the probability of the presence of any active molecule is very low. 2, 3 There are several models attempting to explicate how the peculiar homeopathic procedure of succussion can change solvent structure at nanoscopic level and justify the permanence of pharmacological properties throughout dilutions. 4-7 1 Arnica is one of the most popular medications in complementary medicine. This remedy can be extracted from several plant species belonging to the Aesteraceae family including Arnica montana, Arnica chamissonis, Arnica fulgens, Arnica cordifolia and Arnica sororia, and it is widely sold as tincture, ointment, cream, gel, and tablet. In 2009, a study showed that Asteracea-containing remedies were frequently used in German primary care, and their uses were not associated with serious adverse reactions. 8 Arnica can be used as a homeopathic or herbal remedy. There are also Arnica-based complex formulations which can include up to 32 different plant species which share morphological characteristics and therapeutic properties to treat inflammation, wounds, hematoma, and contusion. 9 Among the different varieties, Arnica montana L. is one of the most used varieties and receives different local names including leopard's bane, wolf's bane, mountain tobacco, and mountain snuff. 10 This herb (here referred as Arnica), native of the Siberian mountains and Central Europe, has been used for the treatment of numerous pathological conditions, including pain, stiffness, and swelling associated with trauma, contusions, sprains, myocarditis, cardiac insufficiency, arteriosclerosis, angina pectoris, postoperative clinical conditions, and for symptomatic relief in osteoarthritis. [10] [11] [12] In traditional medicine, patients suffering from traumatic disease often use Arnica as an "alternative" treatment, in the hope of resolving pain and reducing the use of conventional drugs which may cause adverse effects. Furthermore, according to a review concerning the use of alternative and complementary medicine for rheumatological conditions such as osteoarthritis, rheumatoid arthritis, and fibromyalgia, Arnica was used in 18% of patients attending the rheumatology department in a Mexican hospital. 13 In vitro studies have shown that the most active components of Arnica, as well as of other members of the Asteraceae family, are helenalin and other sesquiterpene lactones such as 11a,13-dihydrohelenalin and chamissonolid. Early on, Lyss et al 14 showed that helenalin inhibits the transcriptional factor nuclear factor kappa B (NF-kB) through the alteration and stabilization of the NF-kB/inhibitor of kappa B (IkappaB) complex in T cells, B cells, and epithelial cells and abrogates kappa B-driven gene expression. This represents one of the earliest evidences of the antiinflammatory properties of Arnica. Later work showed that helenalin can inhibit human neutrophil migration and chemotaxis 15 and activities of 5-lipoxygenase and leukotriene C4 synthase. 16 Helenalin dosedependently reduced cell-proliferation in cluster of differentiation (CD)4 + T cells after the activation of the mitochondrial apoptosis pathway and p53 rapid stabilization and nuclear localization. 17 Furthermore, it arrested activated CD4 + T cell cycle in the G2/M phase through an increase in p27 KIP1 , p21 WAF1/CIP1 , and cyclin D2, and a decrease in cyclin B1 and cyclin A. 17 Helenalin also decreased the expression of cellsurface receptors CD25, CD28, CD27, and CD120b which play a key role in NF-kB activation in T cells, 17 supporting the mechanism proposed by Lyss et al in 1997. 14 NF-kB controls the transcription of various cytokine and adhesion molecule genes in addition to genes required for antigen presentation. 18 NF-kB activation is associated with the induction of pain and inflammation, as observed in animal models of inflammatory pain (rat carrageenan pleurisy and mouse carrageenan air pouch), characterized by the release of proinflammatory cytokines (tumor necrosis factor-alpha [TNF-a] and interleukin-1beta [IL-1b]) and local recruitment of leukocytes. 19 The ability of Arnica to inhibit activation of transcription factors NF-kB and nuclear factor of activated T cells and proinflammatory cytokines IL-1b and TNF-a correlate with their quantitative and qualitative content of sesquiterpene lactones. 20 Additionally, Arnica treatment showed a 4.5-fold inhibition of nitric oxide production, a reduction in the levels of inducible nitric oxide synthase and cyclooxygenase-2 protein, a 3-fold reduction in TNF-a level, and prevented nuclear translocation of NF-kB in J774 murine macrophage cells challenged with lipopolysaccharide. 21 Furthermore, in the rat, 21-day oral treatment with Arnica 30 th centesimal dilution (30c) protected against hepatic mitochondrial membrane permeabilization induced by Ca 2+ and/or Fe 2+ -citratemediated lipid peroxidation and fragmentation of proteins due to attacks by reactive oxygen species. 22 In Figure 1 , we have summarized the mechanisms underlying Arnica effectiveness. As an herbal formulation, Arnica is generally used only topically (on the skin) because of side effects which can be observed after oral administration. Oral homeopathic remedies do contain Arnica, but they use an extremely diluted form which is not considered dangerous. The literature concerning Arnica in both phytotherapeutic and homeopathic formulations is rapidly increasing, together with the knowledge of its active principles and putative mechanisms of action. In this review, we grouped clinical evidence into 2 sections. The first group comprises the use of Arnica as topical formulation, either as a phytotherapic extract (higher dosage not succussed) or homeotherapic (diluted and succussed preparations), whereas the second group comprises the use of homeopathic preparations administered by oral or topical route. The focus was on preclinical and clinical use of Arnica for the treatment of inflammatory conditions, in pain management and postoperative settings.
REVIEW CRITERIA
This review gives an overview of the literature in the aforementioned fields, from 1997 to 2013. The principal information sources are drawn from current reading of major complementary and alternative medicine journals, screening of the Hom-Inform Bibliographic Database and Information Service Databases (British Homeopathic Library, http://hominform.soutron. com/), literature search using MEDLINE, the Cochrane Database of Systematic Reviews, and crossreferencing among published articles. Our analysis includes controlled clinical trials (with and without randomization), observational studies, and case series, but it excludes single case reports. We also consulted previously published systematic reviews and metaanalyses which have covered the subject up to now. Finally, some relevant studies concerning the mechanism(s) of action and laboratory studies are reported.
PRECLINICAL STUDIES
Arnica has been used as a single remedy [23] [24] [25] in preclinical models of acute (carrageenan-and homologous bloodinduced rat paw edema) and chronic (nystatin-induced rat paw edema) inflammation and histamine-induced increased vascular permeability. [23] [24] [25] [26] For instance, autologous blood-induced edema was reduced 1, 3, and 5 hours after subplantar but not after oral administration of Arnica 4th decimal dilution (4D), when compared with control animals. 23 Lussignoli et al 26 replicated this finding and showed that administration of Arnica alone or as a homeopathic formulation (Traumeel) an hour before or after the injection of autologous blood, decreased paw edema and enhanced the healing process. Reduction in paw edema coupled with a decrease in systemic interleukin-6 (IL-6) at 5 hours after blood edema induction. 26 Subchronic oral administration of Arnica 6c also reduced carrageenan-induced rat paw edema by 30%. 25 The reduction in paw edema was evident starting from 1 hour post-carrageenan, and lasted at least 6 hours. In the same study, oral treatment with Arnica 6c before 8.5% nystatin-induced inflammation showed a reduction in the edema at 6 hours compared with the control group. However, no effect was observed when administered after nystatin. Furthermore, Arnica 6c blocked histamine-induced increase in vascular permeability when administered 3 days before stimulus. Oral Arnica 6c administered every 15 minutes between 30 and 180 minutes, after 1% kappa carrageenan inoculation, was effective in reducing late but not early edema in the rat when compared with control groups. 24 Edema amelioration coupled with a decrease in the mast cell degranulation and an increase in the lymphatic vessel diameter. Helenalin, a sesquiterpene lactone and one of the main active constituent of Arnica extract, 14 inhibited carrageenan-induced paw edema and complete Freund's adjuvant-induced arthritis in the rat. 27 Topical application of Arnica 3D gel (10%), combined with microcurrent (10 mA for 2 minutes) application, significantly improved wound healing in the linear incision wound model in the rat back. 28 The evidence was consistent with a significantly larger total number of cells and higher percentage of mature collagen fibers in the wound, as assessed by structural and morphometric analysis. Therefore, these results strongly support the relevance of Arnica in the treatment of inflammatory-related processes.
CLINICAL STUDIES

Topical applications of phytotherapeutic preparations
Up to now, several clinical trials involving the use of topical Arnica have been performed aiming to reduce laser-induced bruising and osteoarthritis-related symptoms. We have summarized these studies in Table 1 .
Laser-induced bruising
Daily application of 2 extracts based on a combination of Arnica and stinging nettle (Combudoron liquid and Combudoron gel; 0.5 mL per lesion for 30 minutes for (1) www.americantherapeutics.com 7 days) was tested on erbium YAG laser-induced grade 2 burns. This single-blind randomized study involved 2 healthy male subjects receiving treatment or placebo on their backs at 4 sites. After 1 week of treatment, the diameters of the lesions were only slightly different between treatments. Most notably, the eschars treated with Combudoron fell off earlier than the placebo suggesting that Combudoron has a positive effect on burn healing. 49 In a randomized, double-blind 2-week study, twice a day topical application of Arnica 13 gel on one side of the face, before or after laser treatment was compared with vehicle application on the other hemiface in 19 patients affected by facial telangiectasias without improvement in visual analog scale (VAS) bruising. 11 Contrasting results were obtained in a 2-week double-blind randomized study including 16 healthy patients who underwent creation of 7-mm standard bruises on the upper inner arms by a 595-nm pulsed-dye laser. 48 Comparison of VASbruising scores indicated that 20% Arnica gel reduced bruising when compared with placebo and gel containing 1% vitamin K and 0.3% retinol, whereas comparison with 5% vitamin K gel did not show any significant difference.
Osteoarthritis
In a randomized, double-blind 3-week study which involved 204 patients affected by osteoarthritis of interphalangeal joints of the hands, topical application of a 4-cm gel strip of Arnica (50 g tincture/100 g) 3 times a day showed similar efficacy to ibuprofen (5%) gel in reducing pain, functional capacity of the hand, number of painful joints in both hands and intensity of morning stiffness in the worst affected hand.
Orally administered homeopathic formulations
Homeopathic formulations of Arnica have been largely used in the clinical setting for the management of knee surgery, carpal tunnel syndrome, symptoms associated with wisdom teeth removal, rhytidectomy, rhinoplasty, abdominal hysterectomy, tonsillectomy, hallux valgus surgery, venous surgery, hemarthrosis, aortic valve surgery, prolonged venous perfusion, muscular pain, dental neuralgia, and ankle sprains.
Knee surgery
Brinkhaus et al 42 Homeopathic treatment containing Arnica 5c, Bryonia Alba 5c, Hypericum perforatum 5c, and Ruta graveolens 3D (4-day treatment starting 1 day before the surgery; 5 granules per day) was not superior to placebo in reducing 24-hour morphine consumption after knee ligament reconstruction in a randomized controlled study including 158 patients. 2 
Carpal tunnel syndrome
In a double-blind randomized trial involving 62 patients, Arnica 30c or 6c administered daily from 7 days before to 14 days after surgery (3 tablets) was not effective in reducing bruising, swelling, and pain in patients undergoing elective surgery for carpal tunnel syndrome. 3
Wisdom teeth removal
In a double-blind trial, Arnica 200c administered to 39 patients undergoing the removal of impacted wisdom teeth, was less effective for pain and swelling management compared with placebo or metronidazole. 29 Arnica was also less effective in promoting healing when compared with metronidazole. 29 In a randomized double-blind placebo-controlled crossover trial including 24 patients undergoing prophylactic surgical removal of identical bilaterally impacted mandibular third molars, homeopathic treatment (30D) containing Arnica, Hypericum, Staphysagria, Sedum, Phosphorus, and Plantago did not produce any improvement in VAS pain score, postoperative bleeding and swelling and side effect profile when compared with the control 34 Furthermore, a 33% less reduction in the ability to open the mouth was observed on day 3 after homeopathic treatment with Arnica. Ernst 45 criticized this study, arguing that the doses were fixed and the treatment schedule was not as flexible as homeopathy requires.
Rhytidectomy
Arnica (SinEcch, Alpine Pharmaceuticals, San Raphael, California; 1 dose every 8 hours for 4 days starting from the day of surgery) was used in patients undergoing rhytidectomy to evaluate its efficacy on bruising caused by facelift in a prospective randomized double-blind study including 29 patients. 43 A reduction in ecchymosis was observed at postoperative days 1 and 7 compared with placebo, as assessed by computer-measured skin color changes.
Rhinoplasty
In a randomized double-blind clinical study involving 48 primary rhinoplasty patients, oral Arnica (SinEcch) administered 3 times a day for 4 days and 10 mg intravenous dexamethasone administered intraoperatively and followed by a 6-day oral tapering dose of methyl-prednisone significantly reduced edema rating, but not intensity and extent of ecchymosis at day 2 post-rhinoplasty when compared with the control group. At postoperative day 8, Arnica and control group showed significantly less extent and intensity of ecchymosis when compared with dexamethasone group. Furthermore, no differences in edema rating were observed among groups at this time point. 51
Abdominal hysterectomy
Negative results concerning the effect of Arnica 30c (2 doses preoperatively plus 3 doses postoperatively for 5 days) on pain, analgesia, infection, and postoperative recovery were obtained in a study including 73 women who underwent total abdominal hysterectomy. 35 
Tonsillectomy
Arnica was tested in patients undergoing tonsillectomy. One hundred eleven patients undergoing tonsillectomy were randomized in a double-blind fashion to receive either Arnica 30c or placebo (2 tablets for 6 times in the first postoperative day followed by 2 tablets twice a day for 7 days). 52 Follow-up over 14 days after surgery showed a significant reduction in the VAS pain scores, whereas no difference was observed in analgesic consumption, complications and return to normal activities.
Hallux valgus surgery
Arnica 4D (pills; postoperatively 3 times a day for 4 days) was compared with diclofenac sodium 50 mg (postoperatively 3 times a day for 4 days) in a randomized double-blind clinical study in 88 patients undergoing hallux valgus surgery. 53 Arnica 4D and diclofenac sodium had equivalent efficacy on wound irritation, patient mobility, and use of analgesics, whereas Arnica was inferior to diclofenac sodium as far as VAS pain score was concerned.
Venous surgery
Arnica 5c, administered sublingually the night before and immediately after saphenous surgery, did not reduce postoperative hematomas, as evaluated 6 days postoperatively in a randomized, prospective, multicentric double-blind trial involving 130 patients. 37 
Aortic valve surgery
Negative results were reported in a double-blind clinical study involving 90 patients undergoing aortic valve surgery assessing the efficacy of a combination of Arnica 5c and Bryonia Alba 5c. 47 Five homeopathic granules administered twice a day for 5 days, starting the evening before surgery for 5 days, did not produce any significant change in the volume of blood/liquid in the drains at their removal and postoperative blood/liquid losses at 12 and 24 hours as well as C-reactive protein, pain, temperature, and plasma troponin Ic.
Prolonged venous perfusion
In a double-blind, placebo-controlled clinical study involving patients undergoing prolonged venous perfusion, Arnica 5c reduced pain symptoms, hyperemia, edema, formation of hematomas and improved blood flow, as measured by Doppler flowmetry. Arnica treatment also slightly increased a number of coagulation factors and platelet aggregation. 32 
Muscular pain
In a double-blind randomized study involving 82 marathon runners, 5 pills of Arnica 30D, given twice a day from the evening before until 3 days after the marathon, improved muscle soreness measured by VAS immediately after the competition, but it did not protect from cell damage (creatine kinase, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, sodium, potassium, magnesium, and creatinine were analyzed) measured by muscular enzymatic reaction. 41 Contrasting results were reported in another double-blind randomized clinical study showing that Arnica 30D did not reduce muscle soreness after long-distance running in 519 runners, as assessed by VAS and Linkert scale. 36 In a randomized double-blind trial including 53 patients, Arnica cream applied immediately after performing calf raises and 24-48 hours post-exercise also failed to improve leg pain, motion, and muscle tenderness when compared with placebo. 46 
Dental neuralgia
Arnica was effective for treatment of dental neuralgic pain after tooth extraction 30 in a placebo-controlled randomized clinical trial. Arnica 7c (4 granules) and Hypericum 15c (St John's wort; 4 granules) prescribed alternately at 4-hour intervals for 2 days, starting immediately after clinical examinations, resulted in pain relief experienced by 76% of patients treated with homeopathic combination therapy versus 40% of patients treated with placebo.
Ankle sprains
Arnica tincture spray (41.5 mg) was also tested in combination with hydroxyethyl salicylate (HES; 12.5 mg) and compared with Arnica (41.5 mg), HES (12.5 mg), and placebo for treatment of ankle joint distortionrelated pain in a prospective, randomized, doubleblind, 4-arm parallel group phase 4 study including 570 patients. 50 Application of Arnica plus HES 4-5 times daily improved pain assessed by VAS after quickly walking a distance of approximately 10 m on day 3-4.
In summary, this study suggests that Arnica can act synergistically with other medications such as HES to reduce sprained ankle joint distortion-related pain.
SAFETY OF ARNICA FORMULATIONS
Although the use of homeopathic medicines is growing, these compounds are often deemed safe and risk-free with patients not declaring their use to their general practitioner. Little evidence is available concerning the use of Arnica in pediatric patients. In this regard, herbal products are extensively used to treat children without consulting the pediatrician and without reporting their use before a surgical procedure, as showed in a study by Crowe and Lyons. 54 In this study, the parents of 601 children undergoing ambulatory surgery were asked to fill in a questionnaire about the administration of herbal medicines to their children. Sixty-six percent of children were taking herbal medicines (Arnica and Echinacea were most commonly used) or had taken them in the past, and 84.7% of parents had not told the practitioner about their use, without thinking that herbal products could lead to adverse effects and interact with anesthetic drugs and the surgical procedure itself. These observations confirm that homeopathic drugs may be used safely either in general practice or on self-prescription, although the general practitioner should be informed to avoid a delay in the choice of a classic drug treatment, if required. Further evidence shows that Arnica can be used for external and internal bruising of both mother and newborn infant. 55 Furthermore, Arnica has been extensively used for soft-tissue bruising in a cohort of patients from birth to 8.5 years of age [Avon Longitudinal Study of Parents and Children (ALSPAC)]. 56 A further study involving 6323 babies showed efficacy and safety of Arnica Echinacea powder in the detachment of the umbilical cord (detachment times: 2 days in 5.12%, 3 days in 44.23%, 4 days in 39.74%, 5 days in 3.20%, 6 days in 3.84%, 7 and 8 days in 1.92%, and 9 days in 0.64%) recommending its use as routine procedure in all nurseries. 57 As far as safety and adverse events in the adult population are concerned, Arnica administered topically is generally well tolerated, particularly as gel formulation. 12, 39 Only 1 allergic reaction was reported by Knuesel et al 39 after topical application of Arnica for the treatment of mild-to-moderate knee osteoarthritis. Widrig et al 12 reported side effects occurring only in 5 out of 89 patients receiving Arnica gel for the treatment of hand osteoarthritis. A further clinical trial of topical Arnica gel treatment for laser-induced bruises did not report any adverse reactions. 11 Another report evaluated the irritating and sensitizing potential of Arnica on 22 subjects without observing any adverse effects. 58 When administered orally, Arnica is safe and well tolerated only at very low concentrations, such as those used in homeopathic medicines. 40, 59 Therefore, Arnica's good tolerability and efficacy proved that Arnica in gel formulation, as well as in homeopathic dilutions for oral use, is an important therapeutic agent which can be used for pain relief, posttraumatic edema, and in the postoperative setting. Furthermore, in certain cases, such as local and generalized pain, the simultaneous administration of topical and orally administered Arnica, besides being safe and well tolerated, is indicated 38 because of the therapeutic synergy created between the two administration routes. We have summarized the studies reporting on Arnica side effect profile in Table 2 .
DISCUSSION
Over the past twenty years, the use of homeopathic medicines has increased worldwide in terms of both prescriptions by physicians and increased recommendation by pharmacists. In particular, Arnica is one of the homeopathic remedies used for over 100 years for the treatment of trauma-associated pain and swelling. This review summarizes the available preclinical and clinical evidence concerning the efficacy and safety of the homeopathic product Arnica in pain-related processes. Overall, Arnica (topical and/or oral formulations) has demonstrated reproducible clinical benefits, some of which are comparable with antiinflammatory drugs such as diclofenac, 53 ibuprofen 12, 60 and corticosteroids 51 which are considered the therapeutics of choice for the treatment of osteoarthritis, postoperative edema, and ecchymosis. 61 Although limited evidence is available for the use of Arnica in the context of wound healing, a study suggests that it can be used instead of diclofenac after hallux valgus surgery to reduce wound irritation and at a lower cost. 53 Furthermore, combined with stinging nettle, it showed promising results in 2 patients with grade 2 laser-induced burns. 49 In patients undergoing the removal of impacted wisdom teeth, Arnica was less effective for the management of pain and swelling compared with placebo suggesting that it should not be used in that clinical condition. 29 These findings suggest that Arnica can be used in the context of wound healing in selected clinical scenarios. However, the limited number of studies warrants further investigations. The topical use of Arnica is supported by studies evincing its efficacy in relieving acute muscle pain after excessive exercise, 62 and in the symptomatic treatment of osteoarthritis. 12, 39 The local action is exerted: (1) at the level of the locomotor system on the muscles, calming the feeling of soreness and pain 63 ; (2) in the joints, reducing the swelling and pain caused by rheumatic disorders; (3) in the capillaries and veins, reducing hematoma and ecchymosis and protecting blood vessels. 20, 62 Additionally, Arnica administered orally in homeopathic dilutions showed positive clinical effects in reducing postoperative pain, swelling, edema, and ecchymosis. 40, 42, 51, 52 Furthermore, topical Arnica combined with oral homeopathic dilutions significantly reduced postoperative pain. 38 As to topical gels, this review points out that Arnica has clinical benefits in relieving pain and surgical complications. The topical application of Arnica thus offers an alternative to ibuprofen because of the high concentration of sesquiterpenes, 12 and in particular helenalin, which is the active substance held responsible for its antiinflammatory activity. 14 The level of sesquiterpenes depends on multiple factors. For example, Douglas et al 64 showed that the total amount of bioactive endogenous sesquiterpenes varies depending on which portion of the plant is being used. The concentration of sesquiterpenes was found to be higher in the disc florets than in the ray florets, lower in the receptacle, and even lower in the stalk. 64 This variability in the quantity of sesquiterpenes, with a consequent variation in the biological activity, can influence the clinical efficacy of Arnica. 20 To guarantee the efficacy of medicines containing Arnica, it is necessary to obtain a phytocomplex with optimal levels of active substances. This requires the use of high-quality raw material that is obtained by harvesting whole, fresh and spontaneously occurring Arnica in its natural habitat, far from any form of pollution and during the balsamic phase. Reproducibility is assured by accurate botanical identification, safeguarding the freshness of the batch, and performing checks on the raw material and the finished product. The quality and safety of homeopathic medicines containing Arnica are guaranteed by the European Pharmacopoeia and by specific Arnica monographs included in the pharmacopoeias of the individual member states. Pharmaceutical companies which produce homeopathic medicines containing Arnica in compliance with these standards are able to guarantee its efficacy and safety. Specifically, Arnica use in various clinical settings is achieving a wider reputation supported by an arising number of open studies, even if comparison of this compound with traditional drugs has been rarely performed.
CONCLUSIONS
Cumulative evidence suggests that both Arnica in gel formulation and in homeopathic dilutions are more effective than placebo in treating several inflammatory conditions, in pain management and postoperative settings. Its clinical efficacy in these fields and its high tolerability make it a potential therapeutic alternative target to non-steroidal anti-inflammatory drugs, especially for patients undergoing pharmacological polytherapy as they are more exposed to the risk of drug interactions and, consequently, to their toxicity. The wide variability of formulations and therapeutic settings precludes a meta-analysis that could assess the efficacy of specific protocols. Further trials involving larger cohorts of patients are needed to support a possible effect of Arnica in several inflammatory conditions, in pain management and postoperative settings.
